Retour sur lavenir.net
   CMB.TECH 13.460 € (0,00 %)     ARGENX SE 786.600 € (-0,41 %)     AEDIFICA 70.950 € (+0,50 %)     AB INBEV 72.400 € (+1,80 %)     SIPEF 92.700 € (+0,32 %)     SOLVAY 26.380 € (+0,61 %)     UCB 245.100 € (-0,28 %)     KBC 122.800 € (+0,04 %)     KBC ANCORA 87.200 € (+0,11 %)     ASCENCIO 52.200 € (-0,38 %)     PROXIMUS 6.280 € (+1,78 %)     SYENSQO 71.225 € (+1,10 %)     ACKERMANS V.HAAREN 264.100 € (+0,42 %)     MELEXIS 68.150 € (-0,73 %)     UMICORE 19.900 € (-0,80 %)     ELIA GROUP 136.000 € (0,00 %)     FAGRON 23.100 € (-0,22 %)     GBL 77.900 € (+0,19 %)     RETAIL ESTATES 66.100 € (+0,61 %)     BPOST 1.520 € (+0,26 %)     WDP 22.700 € (+0,27 %)     BEKAERT 41.550 € (+0,24 %)     SHURGARD 26.000 € (+0,39 %)     VGP 85.000 € (+0,59 %)     CENERGY 20.640 € (-0,58 %)     ONTEX GROUP 2.280 € (+1,33 %)     DEME GROUP 165.400 € (-0,12 %)     KINEPOLIS GROUP 39.500 € (-0,25 %)     AGEAS 71.550 € (+0,21 %)     IBA 16.200 € (-0,12 %)     AZELIS GROUP 10.670 € (+1,04 %)     BARCO 8.035 € (+0,31 %)     AGFA-GEVAERT 0.375 € (+1,35 %)     D'IETEREN GROUP 180.650 € (+1,32 %)     DECEUNINCK 2.215 € (-0,67 %)     LOTUS BAKERIES 10 880.000 € (+1,68 %)     WERELDHAVE BELGIUM 53.400 € (0,00 %)     CELYAD ONCOLOGY 0.289 € (0,00 %)     TUBIZE-FIN 208.000 € (-0,86 %)     NYXOAH 1.240 € (-0,96 %)     MONTEA 69.500 € (+0,43 %)     SOFINA 238.000 € (0,00 %)     RECTICEL 11.900 € (-0,34 %)     CAMPINE 207.000 € (-1,43 %)     COLRUYT 38.460 € (+1,00 %)     ATENOR 1.575 € (+1,94 %)     GIMV 44.600 € (+0,11 %)     EVS 27.600 € (+0,73 %)     BANIMMO A 2.960 € (-0,67 %)     VIOHALCO 17.980 € (0,00 %)     SOLVAC NOM(RETAIL) 75.000 € (-0,66 %)     TESSENDERLO 20.800 € (+1,22 %)     BQUE NAT. BELGIQUE 358.000 € (0,00 %)     CIE BOIS SAUVAGE 305.000 € (0,00 %)     ORANGE BELGIUM 21.800 € (0,00 %)     TINC 11.420 € (-0,17 %)     ACCENTIS 0.025 € (-3,85 %)     CARE PROPERTY INV. 12.840 € (+0,78 %)     VASTNED 29.150 € (-0,34 %)     WAREHOUSES ESTATES 39.000 € (0,00 %)  
   EXOSENS 59.100 € (-5,67 %)     VIRIDIEN 82.200 € (-2,38 %)     FDJ UNITED 23.040 € (+0,96 %)     AYVENS 11.540 € (-0,43 %)     CVC CAPITAL 14.310 € (-0,21 %)     OPMOBILITY 12.880 € (+1,10 %)     PLANISWARE 21.900 € (+2,10 %)     B.COM.PORTUGUES 1.061 € (-0,52 %)     ENGIE 26.990 € (-0,04 %)     KERING 249.300 € (+2,66 %)     TOTALENERGIES 74.360 € (-0,03 %)     SANOFI 77.600 € (-0,24 %)     LVMH 476.200 € (+2,01 %)     SARTORIUS STED BIO 164.000 € (+0,80 %)     STMICROELECTRONICS 45.720 € (-0,36 %)     CREDIT AGRICOLE 18.635 € (+0,13 %)     AIR LIQUIDE 172.980 € (-2,37 %)     LEGRAND 131.950 € (+0,04 %)     AKZO NOBEL 58.780 € (+0,58 %)     PERNOD RICARD 66.140 € (+2,07 %)     VEOLIA ENVIRON. 35.630 € (-1,17 %)     SONAE 2.040 € (+0,74 %)     MICHELIN 34.230 € (-1,95 %)     STELLANTIS NV 5.032 € (+1,41 %)     RENAULT 26.950 € (+1,70 %)     SAINT GOBAIN 76.620 € (+2,54 %)     SOCIETE GENERALE 77.650 € (-0,56 %)     UNILEVER 57.800 € (+6,84 %)     QUADIENT 13.300 € (+1,53 %)     ACCOR 46.400 € (+1,07 %)     VALLOUREC 21.420 € (-0,97 %)     AHOLD DEL 34.730 € (+1,49 %)     ASML HOLDING 1 410.200 € (-1,37 %)     AIRBUS 210.500 € (+0,77 %)     AEGON 8.022 € (-0,74 %)     SBM OFFSHORE 31.720 € (-1,86 %)     BNP PARIBAS ACT.A 108.200 € (+0,58 %)     PHILIPS KON 21.280 € (-9,56 %)     SCHNEIDER ELECTRIC 264.900 € (-0,26 %)     MAAT PHARMA 2.785 € (+0,18 %)     ATOS GROUP 31.140 € (+1,24 %)     CAPGEMINI 96.260 € (+1,20 %)     ASR NEDERLAND 70.040 € (-0,03 %)     BE SEMICONDUCTOR 202.300 € (-1,37 %)     KALRAY 7.980 € (+4,04 %)     AB SCIENCE 0.629 € (-9,89 %)     NANOBIOTIX 34.900 € (-0,96 %)     HERMES INTL 1 705.000 € (+2,77 %)     ABC ARBITRAGE 5.110 € (-0,20 %)     VIVENDI SE 1.967 € (+1,55 %)     ORANGE 16.980 € (+3,44 %)     EUTELSAT COMMUNIC. 2.141 € (+1,95 %)     HEINEKEN HOLDING 72.200 € (+1,83 %)     CSG 16.500 € (+1,48 %)     Vusion 134.000 € (+2,29 %)     TEIXEIRA DUARTE 0.500 € (+0,40 %)     ADYEN 836.200 € (+0,05 %)     2CRSI 26.420 € (-2,15 %)     WOLTERS KLUWER 68.480 € (+1,66 %)     ALSTOM 16.505 € (+1,82 %)  
News Réglementées
16/01/2023 14:45

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( )
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

16-Jan-2023 / 13:45 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

12 January 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

17,987,292

2.44%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

17,987,292

2.44%

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

1,688

4.97 GBP

10p ordinary

Purchase

3,312

4.98 GBP

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière